Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Influenza Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Influenza Therapeutics Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Influenza Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Vaccines
    • 1.4.3 Drugs
  • 1.5 Market by Application
    • 1.5.1 Global Influenza Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinic
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Influenza Therapeutics Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Influenza Therapeutics Industry
      • 1.6.1.1 Influenza Therapeutics Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Influenza Therapeutics Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Influenza Therapeutics Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Influenza Therapeutics Market Perspective (2015-2026)
  • 2.2 Influenza Therapeutics Growth Trends by Regions
    • 2.2.1 Influenza Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Influenza Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Influenza Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Influenza Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Influenza Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Influenza Therapeutics Players by Market Size
    • 3.1.1 Global Top Influenza Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Influenza Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Influenza Therapeutics Market Concentration Ratio
    • 3.2.1 Global Influenza Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Influenza Therapeutics Revenue in 2019
  • 3.3 Influenza Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Influenza Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Influenza Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Influenza Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Influenza Therapeutics Forecasted Market Size by Type (2021-2026)

5 Influenza Therapeutics Breakdown Data by Application (2015-2026)

  • 5.1 Global Influenza Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Influenza Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Influenza Therapeutics Market Size (2015-2020)
  • 6.2 Influenza Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Influenza Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Influenza Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Influenza Therapeutics Market Size (2015-2020)
  • 7.2 Influenza Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Influenza Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Influenza Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Influenza Therapeutics Market Size (2015-2020)
  • 8.2 Influenza Therapeutics Key Players in China (2019-2020)
  • 8.3 China Influenza Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Influenza Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Influenza Therapeutics Market Size (2015-2020)
  • 9.2 Influenza Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Influenza Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Influenza Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Influenza Therapeutics Market Size (2015-2020)
  • 10.2 Influenza Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Influenza Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Influenza Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Influenza Therapeutics Market Size (2015-2020)
  • 11.2 Influenza Therapeutics Key Players in India (2019-2020)
  • 11.3 India Influenza Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Influenza Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Influenza Therapeutics Market Size (2015-2020)
  • 12.2 Influenza Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Influenza Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Influenza Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Abbott Laboratories Company Details
    • 13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
    • 13.1.3 Abbott Laboratories Influenza Therapeutics Introduction
    • 13.1.4 Abbott Laboratories Revenue in Influenza Therapeutics Business (2015-2020))
    • 13.1.5 Abbott Laboratories Recent Development
  • 13.2 Astrazeneca PLC
    • 13.2.1 Astrazeneca PLC Company Details
    • 13.2.2 Astrazeneca PLC Business Overview and Its Total Revenue
    • 13.2.3 Astrazeneca PLC Influenza Therapeutics Introduction
    • 13.2.4 Astrazeneca PLC Revenue in Influenza Therapeutics Business (2015-2020)
    • 13.2.5 Astrazeneca PLC Recent Development
  • 13.3 Biocryst Pharmaceuticals, Inc.
    • 13.3.1 Biocryst Pharmaceuticals, Inc. Company Details
    • 13.3.2 Biocryst Pharmaceuticals, Inc. Business Overview and Its Total Revenue
    • 13.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Introduction
    • 13.3.4 Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business (2015-2020)
    • 13.3.5 Biocryst Pharmaceuticals, Inc. Recent Development
  • 13.4 Chiron Corporation
    • 13.4.1 Chiron Corporation Company Details
    • 13.4.2 Chiron Corporation Business Overview and Its Total Revenue
    • 13.4.3 Chiron Corporation Influenza Therapeutics Introduction
    • 13.4.4 Chiron Corporation Revenue in Influenza Therapeutics Business (2015-2020)
    • 13.4.5 Chiron Corporation Recent Development
  • 13.5 CSL Limited
    • 13.5.1 CSL Limited Company Details
    • 13.5.2 CSL Limited Business Overview and Its Total Revenue
    • 13.5.3 CSL Limited Influenza Therapeutics Introduction
    • 13.5.4 CSL Limited Revenue in Influenza Therapeutics Business (2015-2020)
    • 13.5.5 CSL Limited Recent Development
  • 13.6 Daiichi Sankyo Co., Ltd.
    • 13.6.1 Daiichi Sankyo Co., Ltd. Company Details
    • 13.6.2 Daiichi Sankyo Co., Ltd. Business Overview and Its Total Revenue
    • 13.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Introduction
    • 13.6.4 Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business (2015-2020)
    • 13.6.5 Daiichi Sankyo Co., Ltd. Recent Development
  • 13.7 Glaxosmithkline PLC
    • 13.7.1 Glaxosmithkline PLC Company Details
    • 13.7.2 Glaxosmithkline PLC Business Overview and Its Total Revenue
    • 13.7.3 Glaxosmithkline PLC Influenza Therapeutics Introduction
    • 13.7.4 Glaxosmithkline PLC Revenue in Influenza Therapeutics Business (2015-2020)
    • 13.7.5 Glaxosmithkline PLC Recent Development
  • 13.8 Mitsubishi Tanabe Pharma Corporation
    • 13.8.1 Mitsubishi Tanabe Pharma Corporation Company Details
    • 13.8.2 Mitsubishi Tanabe Pharma Corporation Business Overview and Its Total Revenue
    • 13.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Introduction
    • 13.8.4 Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business (2015-2020)
    • 13.8.5 Mitsubishi Tanabe Pharma Corporation Recent Development
  • 13.9 Nanotherapeutics Inc.
    • 13.9.1 Nanotherapeutics Inc. Company Details
    • 13.9.2 Nanotherapeutics Inc. Business Overview and Its Total Revenue
    • 13.9.3 Nanotherapeutics Inc. Influenza Therapeutics Introduction
    • 13.9.4 Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business (2015-2020)
    • 13.9.5 Nanotherapeutics Inc. Recent Development
  • 13.10 Protein Sciences Corporation
    • 13.10.1 Protein Sciences Corporation Company Details
    • 13.10.2 Protein Sciences Corporation Business Overview and Its Total Revenue
    • 13.10.3 Protein Sciences Corporation Influenza Therapeutics Introduction
    • 13.10.4 Protein Sciences Corporation Revenue in Influenza Therapeutics Business (2015-2020)
    • 13.10.5 Protein Sciences Corporation Recent Development
  • 13.11 Roche Holding AG
    • 10.11.1 Roche Holding AG Company Details
    • 10.11.2 Roche Holding AG Business Overview and Its Total Revenue
    • 10.11.3 Roche Holding AG Influenza Therapeutics Introduction
    • 10.11.4 Roche Holding AG Revenue in Influenza Therapeutics Business (2015-2020)
    • 10.11.5 Roche Holding AG Recent Development
  • 13.12 Sanofi SA
    • 10.12.1 Sanofi SA Company Details
    • 10.12.2 Sanofi SA Business Overview and Its Total Revenue
    • 10.12.3 Sanofi SA Influenza Therapeutics Introduction
    • 10.12.4 Sanofi SA Revenue in Influenza Therapeutics Business (2015-2020)
    • 10.12.5 Sanofi SA Recent Development
  • 13.13 Shionogi & Co., Ltd.
    • 10.13.1 Shionogi & Co., Ltd. Company Details
    • 10.13.2 Shionogi & Co., Ltd. Business Overview and Its Total Revenue
    • 10.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Introduction
    • 10.13.4 Shionogi & Co., Ltd. Revenue in Influenza Therapeutics Business (2015-2020)
    • 10.13.5 Shionogi & Co., Ltd. Recent Development
  • 13.14 Sinovac Biotech Ltd.
    • 10.14.1 Sinovac Biotech Ltd. Company Details
    • 10.14.2 Sinovac Biotech Ltd. Business Overview and Its Total Revenue
    • 10.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Introduction
    • 10.14.4 Sinovac Biotech Ltd. Revenue in Influenza Therapeutics Business (2015-2020)
    • 10.14.5 Sinovac Biotech Ltd. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Influenza Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Influenza Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Abbott Laboratories
    Astrazeneca PLC
    Biocryst Pharmaceuticals, Inc.
    Chiron Corporation
    CSL Limited
    Daiichi Sankyo Co., Ltd.
    Glaxosmithkline PLC
    Mitsubishi Tanabe Pharma Corporation
    Nanotherapeutics Inc.
    Protein Sciences Corporation
    Roche Holding AG
    Sanofi SA
    Shionogi & Co., Ltd.
    Sinovac Biotech Ltd.

    Market segment by Type, the product can be split into
    Vaccines
    Drugs
    Market segment by Application, split into
    Hospitals
    Clinic
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Influenza Therapeutics status, future forecast, growth opportunity, key market and key players.
    To present the Influenza Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Influenza Therapeutics are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now